A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 ...

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.